CIK 0000310158 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in NJ · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 65.0 B | 59.3 B | ||
| Net income (USD) | 7.1 B | 9.8 B | ||
| Diluted EPS (USD/shares) | 7.28 | 5.71 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-15 | 25-NSE | 25-NSE | |
| 2026-10-13 | 8-K | 8-K items 5.02 | 2026-10-09 |
| 2026-10-01 | 4 | PRIMARY DOCUMENT | 2026-09-30 |
| 2026-10-01 | 4 | PRIMARY DOCUMENT | 2026-09-30 |
| 2026-10-01 | 4 | PRIMARY DOCUMENT | 2026-09-30 |
| 2026-09-01 | 3 | PRIMARY DOCUMENT | 2026-09-01 |
| 2026-08-13 | 4 | PRIMARY DOCUMENT | 2026-08-13 |
| 2026-08-13 | 144 | 144 | |
| 2026-08-13 | 4 | PRIMARY DOCUMENT | 2026-08-12 |
| 2026-08-12 | 144 | 144 | |
| 2026-08-12 | 144 | 144 | |
| 2026-08-12 | 4 | PRIMARY DOCUMENT | 2026-08-10 |
| 2026-08-11 | 144 | 144 | |
| 2026-08-10 | 144 | 144 | |
| 2026-08-10 | 4 | PRIMARY DOCUMENT | 2026-08-06 |
| 2026-08-07 | 4 | PRIMARY DOCUMENT | 2026-08-05 |
| 2026-08-07 | 4 | PRIMARY DOCUMENT | 2026-08-05 |
| 2026-08-07 | 4 | PRIMARY DOCUMENT | 2026-08-06 |
| 2026-08-07 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-07 | 13F-HR | 13F-HR | 2026-06-30 |
| 2026-08-06 | 144 | 144 | |
| 2026-08-06 | 144 | 144 | |
| 2026-08-05 | 144 | 144 | |
| 2026-08-05 | 144 | 144 | |
| 2026-08-04 | 8-K | FORM 8-K items 2.02,9.01 | 2026-08-04 |
Forms on file (last 1,000): 4 644, 8-K 67, 144 50, 3 34, 11-K 27, 10-Q 25, 424B5 16, SC 13G/A 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=MRK (0.002 USD), /gw/filings/filings?ticker=MRK&form=8-K, /gw/filings/facts?ticker=MRK&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange